Lux Health Tech Acquisition (Lux Health Tech Acquisition) Gross-Profit-to-Asset % : 0.00% (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Lux Health Tech Acquisition's annualized Gross Profit for the quarter that ended in Jun. 2022 was $0.00 Mil. Lux Health Tech Acquisition's average Total Assets over the quarter that ended in Jun. 2022 was $345.54 Mil. Therefore, Lux Health Tech Acquisition's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2022 was 0.00%.

Lux Health Tech Acquisition Gross-Profit-to-Asset % Historical Data

The historical data trend for Lux Health Tech Acquisition's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition Gross-Profit-to-Asset % Chart

Lux Health Tech Acquisition Annual Data

Trend

Dec20

Dec21

Gross-Profit-to-Asset %

Lux Health Tech Acquisition Quarterly Data
	Aug20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Lux Health Tech Acquisition's Gross-Profit-to-Asset %

For the Shell Companies subindustry, Lux Health Tech Acquisition's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lux Health Tech Acquisition's Gross-Profit-to-Asset % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Lux Health Tech Acquisition's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Lux Health Tech Acquisition's Gross-Profit-to-Asset % falls into.

Lux Health Tech Acquisition Gross-Profit-to-Asset % Calculation

Lux Health Tech Acquisition's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2021 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2021 )	/	( (Total Assets (A: Dec. 2020 )	+	Total Assets (A: Dec. 2021 ))	/ count )
	=	0	/	( (346.09	+	345.68)	/ 2 )
	=	0	/	345.885
	=	0.00 %

Lux Health Tech Acquisition's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2022 )	/	( (Total Assets (Q: Mar. 2022 )	+	Total Assets (Q: Jun. 2022 ))	/ count )
	=	0	/	( (345.391	+	345.685)	/ 2 )
	=	0	/	345.538
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2022) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Lux Health Tech Acquisition Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXAU) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

920 Broadway, 11th Floor, New York, NY, USA, 10010

Website

https://www.luxcapital.com

Lux Health Tech Acquisition Corp is a blank check company.

Executives

Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo	director, officer: Chief Executive Officer	1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert	director, 10 percent owner	C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey	director	NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh	director	C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough	officer: CFO and Treasurer	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc	10 percent owner	C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines

From GuruFocus

Lux Health Tech Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 14, 2020

By Business Wire Business Wire • 12-11-2020

Lux Health Tech Acquisition Corp. Announces Closing of $345 Million Initial Public Offering

By Business Wire Business Wire • 10-29-2020